S&P 500
(0.32%) 5 116.17 points
Dow Jones
(0.38%) 38 386 points
Nasdaq
(0.35%) 15 983 points
Oil
(-1.35%) $82.72
Gas
(6.34%) $2.05
Gold
(0.01%) $2 347.50
Silver
(-0.30%) $27.45
Platinum
(4.08%) $959.70
USD/EUR
(-0.21%) $0.933
USD/NOK
(-0.35%) $10.99
USD/GBP
(-0.54%) $0.796
USD/RUB
(1.66%) $93.40

Sanntidsoppdatering for Eris Lifesciences Limited [ERIS.NS]

Børs: NSE Sektor: Healthcare Industri: Drug Manufacturers—Specialty & Generic
Sist oppdatert29 apr 2024 @ 11:59

0.06% INR 893.50

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 11:59):

Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, anti–diabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology...

Stats
Dagens volum 44 956.00
Gjennomsnittsvolum 217 332
Markedsverdi 121.56B
EPS INR0 ( 2024-02-13 )
Neste inntjeningsdato ( INR0 ) 2024-05-14
Last Dividend INR7.35 ( 2022-08-11 )
Next Dividend INR0 ( N/A )
P/E 31.46
ATR14 INR1.258 (0.14%)

Volum Korrelasjon

Lang: 0.14 (neutral)
Kort: 0.46 (neutral)
Signal:(61.198) Neutral

Eris Lifesciences Limited Korrelasjon

10 Mest positive korrelasjoner
NECCLTD.NS0.892
BINDALAGRO.NS0.889
ROSSARI.NS0.887
SETFNIF50.NS0.882
AXISNIFTY.NS0.881
INDIANHUME.NS0.881
KOTAKNIFTY.NS0.88
ICICINIFTY.NS0.879
LICNFNHGP.NS0.879
BSLNIFTY.NS0.878
10 Mest negative korrelasjoner
SOMATEX.NS-0.88
JSL.NS-0.873
4THDIM.NS-0.859
KARDA.NS-0.839
BSELINFRA.NS-0.83
ISMTLTD.NS-0.819
GAIL.NS-0.817
KIRLFER.NS-0.815
FOSECOIND.NS-0.809
TARMAT.NS-0.804

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Eris Lifesciences Limited Korrelasjon - Valuta/Råvare

The country flag 0.03
( neutral )
The country flag 0.10
( neutral )
The country flag 0.42
( neutral )
The country flag -0.04
( neutral )
The country flag 0.68
( moderate )
The country flag -0.37
( neutral )

Eris Lifesciences Limited Økonomi

Annual 2022
Omsetning: INR16.62B
Bruttogevinst: INR13.09B (78.80 %)
EPS: INR28.10
FY 2022
Omsetning: INR16.62B
Bruttogevinst: INR13.09B (78.80 %)
EPS: INR28.10
FY 2022
Omsetning: INR13.26B
Bruttogevinst: INR10.65B (80.33 %)
EPS: INR29.89
FY 2021
Omsetning: INR11.93B
Bruttogevinst: INR9.51B (79.72 %)
EPS: INR26.16

Financial Reports:

No articles found.

Eris Lifesciences Limited Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR7.35
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)

Eris Lifesciences Limited Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.44 - low (14.40%) | Divividend Growth Potential Score: 5.03 - Potential for dividend initiation, but uncertain (0.67%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR2.87 2020-03-19
Last Dividend INR7.35 2022-08-11
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 4 --
Total Paid Out INR21.73 --
Avg. Dividend % Per Year 0.44% --
Score 1.99 --
Div. Sustainability Score 3.44
Div.Growth Potential Score 5.03
Div. Directional Score 4.23 --
Next Divdend (Est)
(2024-10-30)
INR0 Estimate 0.00 %
Dividend Stability
0.06 Very Bad
Dividend Score
1.99
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2020 INR8.37 1.69%
2021 INR6.01 1.02%
2022 INR7.35 0.96%
2023 INR0 0.00%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SOUTHBANK.NS Dividend Junior 2023-08-17 Sporadic 25 0.42%
MONARCH.NS Dividend Junior 2023-09-14 Annually 3 0.20%
HERANBA.NS Dividend Junior 2023-08-17 Annually 4 0.20%
BHEL.NS Dividend Junior 2023-08-11 Annually 21 0.26%
RAMCOIND.NS Dividend Junior 2023-08-02 Annually 23 0.32%
KOKUYOCMLN.NS Dividend Junior 2023-07-20 Sporadic 16 0.16%
EQUITASBNK.NS Dividend Junior 2023-07-27 Insufficient data to determine frequency 2 0.56%
ALKEM.NS Dividend Junior 2023-08-09 Semi-Annually 9 0.71%
SWARAJENG.NS Dividend Knight 2023-07-06 Annually 23 2.81%
NELCO.NS Dividend Junior 2023-06-06 Sporadic 22 0.24%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2101.5005.808.70[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.1671.5009.2610.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM8.081.0008.128.12[3 - 30]
operatingCashFlowPerShareTTM19.152.003.627.23[0 - 30]
freeCashFlowPerShareTTM19.152.000.4240.847[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.8181.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.2661.0006.676.67[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score3.44

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM31.611.0006.910[1 - 100]
returnOnEquityTTM0.1672.509.5210.00[0.1 - 1.5]
freeCashFlowPerShareTTM19.152.003.620.847[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM19.152.003.627.23[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM2.221.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1421.0008.960[0.1 - 0.5]
Total Score5.03

Eris Lifesciences Limited

Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, anti–diabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.